This program is for young people aged 12 to 21 who have severe symptoms from gastroesophageal reflux disease (GERD) or other stomach motility problems, like nausea, vomiting, or severe indigestion. These are people whose conditions haven't improved with standard treatments. The study aims to see if domperidone, taken four times a day, can help reduce the severity of these symptoms. Doctors will adjust the dose of domperidone based on your body weight. The main goal is to see how much your disease severity changes over up to one year. This study plans to include 20 participants, but its current status is unclear.

Study design

This is an interventional study planning to enroll 20 participants aged 12 to 21.

What's involved

You will have a medical history review, physical exam, ECG (a test of your heart's electrical activity), and blood draws before starting. If eligible, you will take domperidone four times daily, and have physical exams, blood draws, and ECGs every two months for the first year.

Compensation

Not stated in the trial record.

Follow-up

You will be followed for changes in disease severity for up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.